Olema Pharmaceuticals Inc (NASDAQ: OLMA) on Friday, plunged -9.35% from the previous trading day, before settling in for the closing price of $30.81. Within the past 52 weeks, OLMA’s price has moved between $2.86 and $36.26.
During the last 5-year period, the sales drop of Healthcare Sector giant was -83.00%. The company achieved an average annual earnings per share of 12.42%. With a float of $65.65 million, this company’s outstanding shares have now reached $68.65 million.
Olema Pharmaceuticals Inc (OLMA) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Olema Pharmaceuticals Inc is 16.54%, while institutional ownership is 75.10%. The most recent insider transaction that took place on Dec 19 ’25, was worth 1,553,447. Before that another transaction happened on Dec 19 ’25, when Company’s Officer proposed sale 70,000 for $28.19, making the entire transaction worth $1,973,561.
Olema Pharmaceuticals Inc (OLMA) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.51 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.17) by -0.68. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.31% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Olema Pharmaceuticals Inc (OLMA) is currently performing well based on its current performance indicators. A quick ratio of 8.03 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -2.24 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Looking closely at Olema Pharmaceuticals Inc (NASDAQ: OLMA), its last 5-days average volume was 3.46 million, which is a jump from its year-to-date volume of 1.65 million. As of the previous 9 days, the stock’s Stochastic %D was 45.37%.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 73.80%, which indicates a significant increase from 21.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.67 in the past 14 days, which was higher than the 1.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.55, while its 200-day Moving Average is $8.43. However, in the short run, Olema Pharmaceuticals Inc’s stock first resistance to watch stands at $30.93. Second resistance stands at $33.94. The third major resistance level sits at $35.87. If the price goes on to break the first support level at $25.99, it is likely to go to the next support level at $24.06. Should the price break the second support level, the third support level stands at $21.05.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
Market capitalization of the company is 2.20 billion based on 68,660K outstanding shares. Right now, sales total 0 K and income totals -129,470 K. The company made 0 K in profit during its latest quarter, and -42,220 K in sales during its previous quarter.
